Harvard Bioscience, Inc. to Present and Host One-on-One Meetings at the 14th Annual East Coast IDEAS Conference on June 12, 2024

Rhea-AI Summary

Harvard Bioscience (Nasdaq: HBIO) will present and host one-on-one meetings at the 14th Annual East Coast IDEAS Conference in New York City on June 12, 2024. Chairman and CEO Jim Green, along with CFO Jennifer Cote, will address investors from 2:45-3:20 PM ET at the Jay Conference Center – Bryant Park. The presentation will be webcast live and accessible via the company's investor relations website, with a replay available shortly afterward. To schedule individual meetings, investors should contact the conference team at Three Part Advisors.

Positive

• Opportunity for direct investor engagement.
• Increased visibility through participation in a major conference.
• Live webcast enhances transparency and accessibility.
• Potential to attract new investors and boost stock performance.

Negative

• No direct financial or clinical updates provided.
• Unclear impact on immediate stock performance.

HOLLISTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will be presenting to investors at the 14^th Annual East Coast IDEAS Conference at the Jay Conference Center – Bryant Park in New York City on June 12, 2024.

The Company’s presentation is scheduled for 2:45-3:20 PM ET on June 12th. The Company will also host one-on-one investor meetings throughout the day. The presentation will be webcast live and can be accessed through the investor relations section of the Harvard Bioscience website at https://investor.harvardbioscience.com. A replay will be available shortly after the presentation has concluded. To schedule a one-on-one meeting, please contact the Three Part Advisors conference team at (817) 769-2373 or lwesley@IDEASconferences.com.

About Harvard Bioscience, Inc.  

Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world.  

For more information, please visit our website at www.harvardbioscience.com.

Company Contact:

Harvard Bioscience
Jennifer Cote, Chief Financial Officer
(508) 893-3120

Investor Contacts:

Three Part Advisors
Sandy Martin / Erol Girgin / William Shelmire
HBIO@threepa.com
(214) 616-2207

FAQ

What is the date and time for Harvard Bioscience's presentation at the IDEAS Conference?

Harvard Bioscience's presentation at the IDEAS Conference is scheduled for June 12, 2024, from 2:45-3:20 PM ET.

Who will present for Harvard Bioscience at the IDEAS Conference 2024?

Jim Green, Chairman and CEO, along with Jennifer Cote, CFO, will present for Harvard Bioscience.

Where can I watch the live webcast of HBIO's presentation at the IDEAS Conference?

The live webcast of HBIO's presentation can be accessed through the investor relations section of the Harvard Bioscience website.

How can investors schedule one-on-one meetings with Harvard Bioscience at the IDEAS Conference?

Investors can schedule one-on-one meetings by contacting the Three Part Advisors conference team at (817) 769-2373 or lwesley@IDEASconferences.com.

What is the location of the 14th Annual East Coast IDEAS Conference?

The 14th Annual East Coast IDEAS Conference will be held at the Jay Conference Center – Bryant Park in New York City.